Pip Care to Improve Surgical Patient Outcomes
Public ClinicalTrials.gov record NCT06661291. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Utilization of Digital Health Platform Plus Live Coaching Improves Surgical Patients Outcomes - Phase II
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Pip Care is developing a personalized, interactive surgical journey platform with a live health coach that works directly with health systems to optimize the perioperative care process. Our Health Insurance Portability and Accountability Act (HIPAA)-compliant platform, Pip, can be integrated into any electronic medical record (EMR), thus alleviating the administrative burden by making operational workflows more efficient. The PIP empowers patients and their families to be more involved in their care by breaking down a patient's healthcare plan into definable, easy-to-understand, and easy-to-complete tasks. Additionally, a health coach completes a health intake to create a personalized perioperative care plan, meets regularly with the patient to encourage goal accomplishment, and facilitates care coordination. This project has 2 phases; Phase I is to assess usability of the Pip Care platform in surgical patients, Phase II is a RCT (Randomized Controlled Trial) to assess surgical clinical outcomes while using Pip compared to standard of care.
Study identification
- NCT ID
- NCT06661291
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 1,300 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 12, 2025
- Primary completion
- Aug 31, 2028
- Completion
- Aug 31, 2028
- Last update posted
- Oct 27, 2025
2025 – 2028
United States locations
- U.S. sites
- 8
- U.S. states
- 1
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UPMC Jameson Hospital | New Castle | Pennsylvania | 16105 | Recruiting |
| UPMC East Hospital | Pittsburgh | Pennsylvania | 15146 | Recruiting |
| UPMC Horizon | Pittsburgh | Pennsylvania | 15213 | Recruiting |
| UPMC Magee Womens Hospital | Pittsburgh | Pennsylvania | 15213 | Recruiting |
| UPMC Presbyterian Hospital | Pittsburgh | Pennsylvania | 15213 | Recruiting |
| UPMC St. Margaret | Pittsburgh | Pennsylvania | 15213 | Recruiting |
| UPMC Shadyside Hospital | Pittsburgh | Pennsylvania | 15232 | Recruiting |
| UPMC Passavant Hospital | Pittsburgh | Pennsylvania | 15237 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06661291, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 27, 2025 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06661291 live on ClinicalTrials.gov.